Cinven acted as the acquirer in this Public Acquisition Offer transaction.
The acquisition targeted assets operating in the Healthcare sector.
The transaction was announced on 29 Sep 2023 with a reported value of 28600000000.0.
Generated by AI, original source from - Data is in progress
SYNLAB AG advisor
Firm name is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Cinven on its public acquisition offer, squeeze-out of minority shareholders, and Elliott's reinvestment in SYNLAB AG. | The Sponsor - The Sponsor
